{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/LSE/HIK",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# HIKMA PHARMACEUTICALS PLC (LSE Main Market: HIK) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is HIKMA PHARMACEUTICALS PLC, listed on the LSE Main Market under ticker HIK, ISIN GB00B0LCW083, LEI 549300BNS685UXH4JI75. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 139 filings across 86 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 3 days. The latest filing is dated 2026-11-05 and is of type financial_statement, 1 day before the record date of 2026-11-06. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days across 892 issuers. In the sector Pharmaceuticals and Biotechnology [201030] the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers.\n\n## Auditor\n\nThe auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.\n\n## Orderability\n\nFor the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 12 research houses: Barclays, Berenberg, BNP Paribas, BofA, Citi, Deutsche Numis, Jefferies, JP Morgan, Panmure Liberum, Peel Hunt, RBC and Stifel.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed. The market earliest sealed date is not on the record. The live record began on 2026-09-11. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.\n\n## Sources\n\n11 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HIK (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/05557934 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/HIK/hikma-pharmaceuticals-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/LSE/HIK (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://www.hikma.com/media/f1ppfora/hikma-ar24-financial-statements.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/ (coverage)\n- https://mcp.uk-cm-kg.ai/record/LSE/HIK (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "Tavily regex",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.hikma.com/media/f1ppfora/hikma-ar24-financial-statements.pdf",
    "state": "confirmed",
    "value": "PricewaterhouseCoopers LLP"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/LSE/HIK",
  "coverage": {
   "count": 12,
   "houses": [
    {
     "analyst": "James Gordon",
     "house": "Barclays",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Beatrice Fairbairn",
     "house": "Berenberg",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Victor Floch",
     "house": "BNP Paribas",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Charlie Haywood",
     "house": "BofA",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Giang Nguyen",
     "house": "Citi",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Kane Slutzkin",
     "house": "Deutsche Numis",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "James Vane-Tempest",
     "house": "Jefferies",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Zain Ebrahim",
     "house": "JP Morgan",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Seb Jantet",
     "house": "Panmure Liberum",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Miles Dixon",
     "house": "Peel Hunt",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Natalia Webster",
     "house": "RBC",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    },
    {
     "analyst": "Christian Glennie",
     "house": "Stifel",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/",
     "result": "read: 12 of 24 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 892,
     "median_cadence_gap_days": 4,
     "median_filings": 29,
     "median_latency_days": 3,
     "name": "LSE Main Market"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 1,
    "ch_accounts_filed": 1,
    "ch_capital": 44,
    "ch_confirmation_statement": 1,
    "ch_officer_change": 13,
    "ch_other": 2,
    "ch_resolution": 1,
    "corporate_action": 41,
    "director_dealing": 15,
    "early_warning": 11,
    "financial_statement": 5,
    "regulatory_announcement": 4
   },
   "cadence_median_gap_days": 3,
   "filing_days": 86,
   "filings": 139,
   "latency_days": 1,
   "latest": [
    {
     "category": null,
     "date": "2026-11-05",
     "source": "https://www.investegate.co.uk/announcement/rns/hikma-pharmaceuticals--hik/trading-statement/9859112",
     "title": "Trading Statement",
     "type": "financial_statement"
    },
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.investegate.co.uk/announcement/rns/hikma-pharmaceuticals--hik/holding-s-in-company/9834798",
     "title": "Holding(s) in Company",
     "type": "early_warning"
    },
    {
     "category": null,
     "date": "2026-10-20",
     "source": "https://www.investegate.co.uk/announcement/rns/hikma-pharmaceuticals--hik/holding-s-in-company/9832415",
     "title": "Holding(s) in Company",
     "type": "early_warning"
    },
    {
     "category": null,
     "date": "2026-10-12",
     "source": "https://find-and-update.company-information.service.gov.uk/company/05557934/filing-history/MzU0OTI4NjQ0OWFkaXF6a2N4/document?format=pdf&download=0",
     "title": "capital cancellation shares — 2026-08-25",
     "type": "ch_capital"
    },
    {
     "category": null,
     "date": "2026-10-06",
     "source": "https://find-and-update.company-information.service.gov.uk/company/05557934/filing-history/MzU0OTA0NTIwNWFkaXF6a2N4/document?format=pdf&download=0",
     "title": "capital return purchase own shares",
     "type": "ch_capital"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/HIK",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "LSE Main Market"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HIK",
    "state": "confirmed",
    "value": "GB00B0LCW083"
   },
   "jurisdiction": {
    "read_by": "Companies House REST API (company profile) (jurisdiction field)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/05557934",
    "state": "confirmed",
    "value": "England and Wales (Companies House jurisdiction field)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00B0LCW083)",
    "state": "sourced",
    "value": "549300BNS685UXH4JI75"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "HIKMA PHARMACEUTICALS PLC"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/HIK/hikma-pharmaceuticals-plc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "STMM"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "HIK"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/HIK/hikma-pharmaceuticals-plc/company-page",
    "state": "sourced",
    "value": "www.hikma.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:25795a969b340f32fc239c63ff2c6fee73997d51521fbb7c6f4ce99db0267505",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/LSE/HIK",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:25795a969b340f32fc239c63ff2c6fee73997d51521fbb7c6f4ce99db0267505",
 "path": "/uk/LSE/HIK",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is HIKMA PHARMACEUTICALS PLC, listed on the LSE Main Market under ticker HIK, ISIN GB00B0LCW083, LEI 549300BNS685UXH4JI75. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 139 filings across 86 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 3 days. The latest filing is dated 2026-11-05 and is of type financial_statement, 1 day before the record date of 2026-11-06. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days across 892 issuers. In the sector Pharmaceuticals and Biotechnology [201030] the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is PricewaterhouseCoopers LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 12 research houses: Barclays, Berenberg, BNP Paribas, BofA, Citi, Deutsche Numis, Jefferies, JP Morgan, Panmure Liberum, Peel Hunt, RBC and Stifel.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed. The market earliest sealed date is not on the record. The live record began on 2026-09-11. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "11 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HIK"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://find-and-update.company-information.service.gov.uk/company/05557934"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/HIK/hikma-pharmaceuticals-plc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/HIK"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://www.hikma.com/media/f1ppfora/hikma-ar24-financial-statements.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.hikma.com/investors/company-compiled-consensus/analyst-coverage/"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/LSE/HIK"
  }
 ],
 "title": "HIKMA PHARMACEUTICALS PLC (HIK) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}